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NF-κBThe leader proteinase (Lpro) of foot-and-mouth disease virus (FMDV) plays a critical role in viral
pathogenesis. Molecular studies have demonstrated that Lpro inhibits translation of host capped mRNAs
and transcription of some genes involved in the innate immune response. We have used microarray
technology to study the gene expression proﬁle of bovine cells infected with wild type (WT) or leaderless
FMDV. Thirty nine out of approximately 22,000 bovine genes were selectively up-regulated by 2 fold or more
in leaderless versus WT virus infected cells. Most of the up-regulated genes corresponded to IFN-inducible
genes, chemokines or transcription factors. Comparison of promoter sequences suggested that host factors
NF-κB, ISGF3G and IRF1 speciﬁcally contributed to the differential expression, being NF-κB primarily
responsible for the observed changes. Our results suggest that Lpro plays a central role in the FMDV evasion of
the innate immune response by inhibiting NF-κB dependent gene expression.Center, USDA, ARS, NAA, P.O.
1 323 3006.
de los Santos).
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Foot-and-mouth disease (FMD) is a highly contagious vesicular
viral disease that affects wild and domestic cloven-hoofed animals
and is considered a major threat to animal health worldwide
(Grubman and Baxt, 2004). The etiologic agent, FMD virus (FMDV)
belongs to the aphthovirus genus of the Picornaviridae family and
contains a single-stranded positive-sense RNA genome of about 8500
bases surrounded by a non-enveloped icosahedral protein capsid.
Upon infection, the viral genome is translated into a long polyprotein
precursor which is subsequently processed by three viral encoded
products, the proteinases Lpro and 3Cpro, and the 18 amino-acid
peptide 2A, resulting in four structural proteins (VP4-1A, VP2-1B,
VP3-1C and VP1-1D) and ten non-structural viral proteins (L, 2A, 2B,
2C, 3A, 3B1,2,3 3C and 3D) (Mason et al., 2003; Ryan et al., 1991). Lpro,
positioned at the N-terminus of the polyprotein, is a papain-like
proteinase that in addition to processing itself from the viral protein
precursor (Strebel and Beck, 1986), is involved in cleaving the host
translation initiation factor eIF4G (Devaney et al., 1988, Kirchweger
et al., 1994). This process results in the shut-off of host cap-dependent
protein synthesis without affecting viral cap-independent protein
translation, thus diverting the cellular machinery to virus production.
We have previously shown that Lpro plays an important role in FMDV
pathogenesis. A genetically engineered FMDV strain lacking the Lpro
coding region (leaderless virus) is viable in tissue culture (Picconeet al., 1995) but remarkably, it does not cause clinical disease when
inoculated into cattle or swine (Mason et al., 1997; Chinsangaram
et al., 1998) and it does not spread from the original site of infection
when aerosolized in cattle (Brown et al., 1996). Further studies
have demonstrated that supernatants of primary cell cultures infected
with leaderless virus contain higher levels of antiviral activity
than supernatants of cells infected with wild type (WT) virus
(Chinsangaram et al., 1999). Using cells derived from knockout mice
for type I interferon (IFN)-receptor, double-stranded RNA-dependent
protein kinase (PKR) or RNase L, it was demonstrated that the
antiviral activity elicited by leaderless virus was type I IFN-speciﬁc
(Chinsangaram et al., 2001). Furthermore, viral replication was
inhibited by pre-treatment of cells with IFN-α, suggesting that
FMDV cannot overcome the antiviral effects of IFN stimulated genes
(ISGs) once they have been established (Chinsangaram et al., 2001).
More recently, we have found that in addition to blocking IFN protein
synthesis, FMDV Lpro also inhibits the induction of transcription of
IFN-β and at least three ISGs including PKR, 2′, 5′ oligoadenylate
synthetase (OAS1) and Mx1 (de los Santos et al., 2006). Moreover, we
have observed that FMDV inhibition of cellular transcription corre-
lates with degradation of the p65 subunit of the transcription factor,
nuclear factor-κB (NF-κB) (de los Santos et al., 2007). The intrinsic
proteinase activity of Lpro and its proper nuclear localization and
retention are required for this function (de los Santos et al., 2007,
2009).
NF-κB belongs to a conserved family of proteins that formmultiple
homo- and heterodimers with transcriptional activity (Hayden et al.,
2006). In resting cells, NF-κB dimers are retained in the cytoplasm by
their interaction with speciﬁc protein inhibitors known as IκBs. A
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triggers a cascade of signal transduction events leading to phosphor-
ylation of IκBs, which are subsequently ubiquitinated and degraded by
the proteasome. These events result in the release of NF-κB from IκB,
followed by translocation into the nucleus. Once in the nucleus, NF-κB
binds speciﬁc sequences in the promoter/enhancer regions of
numerous genes including cytokines, chemokines and other products
involved in the regulation of cellular differentiation, survival and
proliferation, thereby controlling various aspects of the innate and
adaptive immune response (Hayden and Ghosh, 2008). Transcription
of hundreds of genes is regulated by the signaling events activated by
IFNs and by NF-κB. More than 300 ISGs have been reported as induced
by human type I IFNs (Der et al., 1998, de Veer et al., 2001) and more
than 500 genes may be affected by NF-κB (Gilmore, 2008).
In this study we have taken a functional genomics approach using
microarray technology to systematically study the differences in gene
expression induced by WT and leaderless FMDV infection of primary
bovine cells. We have examined the pattern of expression of 43,803
bovine gene probes, corresponding to approximately 22,000 genes,
using a custom designed bovine microarray. Consistent with our
previous data, we found that in cells infected with leaderless FMDV
there is a signiﬁcant increase in the levels of expression of several
genes, most of them involved in the innate immune response. Our
analysis suggests that Lpro modulates multiple pathways of the
cellular response to viral infection by primarily interfering with NF-
κB dependent gene expression.
Results
Differentially expressed genes between WT and leaderless FMDV infected
cells
In the current study we analyzed gene expression upon FMDV
infection of bovine cells (embryonic bovine kidney cells [EBK]). Cells
were infected at a multiplicity of infection (MOI) of 10 and RNA
samples collected at 2, 4 and 6h post infection (hpi). Since the RNA
extracted from WT infected cells at 6 hpi showed signs of partial
degradation, microarray analyses were performed with samples
collected at 2 and 4 hpi. RNA extracted from mock infected cells
served as a normalizer for indirect comparison between WT and
leaderless virus and gene transcriptional differences were reported as
the relative expression in leaderless with respect to WT virus
infection. We found that no genes were differentially expressed by
2-fold or more (leaderless vs WT virus) in samples taken at 2 hpi, and
no cytopathic effect (CPE) was observed in the cultures (data not
shown). However, by 4 hpi the gene expression proﬁle for both
viruses was signiﬁcantly different and approximately 20% and 5% CPE
was observed in the WT and leaderless virus infected cells,
respectively. Three biological replications were performed with
samples taken at 4 hpi. Based on the signiﬁcant threshold of false
discovery rate of 0.2 or lower and differential expression equal to or
greater than 2-fold, 39 genes were determined as differentially
expressed in EBK cells infected with leaderless vsWT FMDV (Table 1).
The expression of all 39 genes was up-regulated in leaderless as
compared to WT virus infected cells, suggesting that Lpro had an
inhibitory effect on gene expression. Analysis of the available
literature indicated that the majority of the differentially expressed
genes (DEGs) were IFN-stimulated and included: 1) genes with
antiviral activity (IFIT2, RSDA2, ISG15, OAS1, Mx1 and ZC3HAV1); 2)
cytokines/chemokines (IL28B, CXCL3, CCL2 and CX3CL1); 3) tran-
scription factors (ISGF3G, IRF8); 4) genes involved in regulation of
apoptosis (pro-apoptotic: PMAIP1, SAT1, NF-κB1A and UBE1L; anti-
apoptotic: IER3 and IFI6); 5) Genes involved in cell proliferation
(GBP1); and 6) genes involved in regulation of IFN signaling (LGP2
and USP18). All of the above DEGs were related to the innate immune
response.A number of additional genes not known to be IFN-stimulated,
including transcription factors DSCR1, BATF2, GTF2B, SERTA D1 and
TCFL1 were also up-regulated, in leaderless vs WT infected cells, as
well as genes involved in RNA metabolism such as DTX3L and ZFP36.
We also observed induction of eIF4E a factor required for translation,
PARP14 and TREX1, genes also involved in apoptosis, SLC25A28, a
mitochondrial ion transporter, MARCKSL1, a gene predicted to be
involved in the protein kinase C-calmodulin signal transduction
pathway and FAM46A and C6orf150, genes of unknown functions.
To corroborate the results obtained with the microarray analysis,
we performed quantitative (real time) reverse transcription-poly-
merase chain reaction (qRT-PCR) on a selected group of genes for
which we had a standardized method available in the lab. Similar to
the microarray analysis, we observed up-regulation of CCL2, IL28B,
ISG15, Mx1 and OAS1 (Table 2). Although the differential gene
expression detected with microarray analysis was always smaller
than that measured by qRT-PCR, the fold induction values followed
the same pattern in both assays. In addition, IFN-β was increased by
approximately 50-fold and PKR by 2.3 fold for leaderless as compared
toWT virus infection. In summary, there was consistency between the
results of microarray and qRT-PCR analyses showing both, a higher
level of expression of genes that participate in the stress/antiviral
cellular immune response in leaderless virus infected as compared to
WT virus infected cells.
Inferred transcription factors involved in the differential expression
Transcription is a process tightly regulated by the binding of
transcription factors to promoter and regulatory sequences. Using the
Neural Network Promoter Prediction (NNPP) program and expression
sequences, we were able to predict the promoter sequences of 35 out
of the 39 DEGs that were further analyzed with the Over-represented
Transcription Factor Binding Site Prediction Tool (OTFBS). When
comparing to random sequences, we detected six transcription factor-
binding matrices over-represented (33 to 137 hits) in the selected
regions of the regulatory sequences with P-values≤5.92E−05
(Table 3). The transcription factors that bind the over-represented
matrices included ISGF3G, IRF1, IRF2, NF-κB (two reported matrices
M00194, NFKB_Q6, and M00054, NF-kappaB) and C-rel. For compar-
ison, 33 corresponding human promoter sequences described in the
human promoter database were used in the same analysis (Table 4).
We found that binding sites for NF-κB (NF-kappaB -M00194) and
ISGF3G (interferon-stimulated response element -ISRE-M00258)
were also signiﬁcantly over-represented in the regulatory sequences
of the up-regulated gene probes as compared to the promoter
sequences of all genes included in the microarray. Therefore, both
human and bovine promoter sequences of the DEGs, showed over-
representation for the binding sites of NF-κB and ISGF3G transcription
factors.
Additionally, the number of these transcription factor binding sites
in the upstream regulatory sequences of the bovine DEGs was used to
perform correlation analysis with respect to signal intensity, fold
change or impact factor for the identiﬁed matrices in the 35 DEGs
(Supplementary Table 1). We observed signiﬁcant correlation
between the number of binding sites for ISGF3G and IRF1 and signal
intensity with coefﬁcients of 0.43 and 0.41 and between the number
of binding sites and fold change with coefﬁcients of 0.62 and 0.58,
respectively. With this analysis, however, we did not see signiﬁcant
correlation for the number of NF-κB (NFKAPPAB_01, NFKB_Q6 or
NFKB total) or c-Rel binding sites, although almost all DEGs have these
recognition sequences in their promoters or regulatory elements.
We also analyzed the transcriptional regulatory networks affecting
the differential expression using CARRIE software (Table 5). This
program is a computational method that analyzes microarray data
including signal intensity, fold changes, and promoter sequence data
to infer a transcriptional regulatory network from the response to a
Table 1
List of genes that displayed signiﬁcant differential expression at 4 hpi in primary EBK cells infected with leaderless or WT FMDV.
Gene P-value Q-value Fold Gene description Function Reference
IFIT2 8.54E−06 0.05 11.5 Interferon-induced protein with
tetratricopeptide repeats 2 (ISG54)
ISG. Involved in blocking
translation by binding eIF3
Terenzi et al. (2006).
RSAD2 8.54E−06 0.05 8.1 Radical S-adenosyl methionine
domain containing 2 (viperin)
ISG. Antiviral Chin and Cresswell (2001).
PMAIP1 1.15E−04 0.09 7.1 Phorbol-12-myristate-
13-acetate-induced protein 1
Inducer of apoptosis Oda et al. (2000).
BATF2 1.24E−04 0.09 6.9 Basic leucine zipper transcription
factor, ATF-like 2
Predicted as general transcription factor
activated by MAP kinases in response to stress
Strausberg et al. (2002).
ISG15 6.83E−05 0.08 6.9 ISG15 ubiquitin-like modiﬁer ISG. ISG15 is conjugated to proteins
involved in innate immunity
Loeb and Haas (1992).
CXCL3 4.27E−05 0.08 4.7 Chemokine (C-X-C motif) ligand 3 ISG. Chemokine. Attracts monocytes. Geiser et al. (1993).
SAT1 1.45E−04 0.09 4.5 Spermidine/spermine
N1-acetyltransferase 1
NF-κB regulated. Stops proliferation
and induces apoptosis
Babbar et al. (2006).
IL28B 4.70E−04 0.12 3.8 Interleukin 28B (interferon, lambda 3) ISG. Type III IFN Kotenko et al. (2003).
Sheppard et al. (2003).
OAS1 2.13E−04 0.09 3.8 2′,5′-oligoadenylate synthetase 1 ISG; synthesizes 2′,5′ oligoadenylates that
activate RNase L to degrade viral RNA
Ghosh et al. (1991).
GTF2B 5.98E−05 0.08 3.4 General transcription factor IIB Transcription factor involved in recognition
of promoter sequences during RNA pol II
dependent transcription
Reines et al. (1996).
USP18 1.07E−04 0.09 3.4 Ubiquitin speciﬁc peptidase 18 ISG; removes ISG15 from conjugated proteins Malakhov et al. (2002).
CCL2 2.48E−04 0.10 3.4 Chemokine (C-C motif) ligand 2 ISG; chemokine that recruits immune
cells to site of infection/injury
Carr et al. (1994).
SOCS1 8.54E−05 0.09 3.3 Suppressor of cytokine signaling 1 Inhibits JAK/STAT pathways. Targets
proteins for degradation
Prêle et al. (2008).
ZFP36 5.98E−05 0.08 3.3 Zinc ﬁnger protein 36 Involved in nucleating proteins involved
in silencing AU rich RNA. Binds TNFa and
GMCSF mRNAs promoting instability.
Lai et al. (2002).
CX3CL1 7.22E−04 0.15 3.2 Chemokine (C-X3-C motif) ligand 1 ISG; involved in leukocyte adhesion and
migration at the endothelium.
Bazan et al. (1997).
PARP14 2.99E−05 0.07 3.1 Poly (ADP-ribose) polymerase
family, member 14
Enzyme that modiﬁes histones and other
nuclear proteins by adding poly(ADP-ribosyl)
groups leading to cell death.
Amé et al. (2004).
C6orf150 3.42E−05 0.07 3.0 Chromosome 6 open reading frame 150 Unknown
NFKBIA 9.14E−04 0.16 2.9 Nuclear factor of κ light polypeptide
gene enhancer in B-cells inhibitor, α (IκB α)
Inhibits NF-κB activity by retaining
it in the cytoplasm
Haskill et al. (1991).
IFI6 1.79E−04 0.09 2.9 Interferon, alpha-inducible protein 6 ISG; suppresses apoptosis Tahara et al. (2005).
DTX3L 9.82E−05 0.09 2.7 Deltex 3-like (Drosophila) Ubiquitin ligase activity. Binds promoter regions Takeyama et al. (2003).
FBXO33 3.03E−04 0.10 2.6 F-box protein 33 May work as protein ubiquitin-ligase Jin et al. (2004).
Mx1 1.32E−04 0.09 2.6 Myxovirus (inﬂuenza virus) resistance 1 ISG; antiviral; GTPase that targets
viral RNP structures
Haller et al. (2007).
GBP1 1.96E−04 0.09 2.6 Guanylate binding protein 1 ISG; GTP binding protein; inhibits
endothelial cell proliferation
Guenzi et al. (2001).
UBE1L 6.49E−04 0.14 2.5 Ubiquitin-activating enzyme E1-like E1-ubiquitin activating enzyme. Induces apoptosis. Kitareewan et al. (2002).
ZNFX1 1.71E−04 0.09 2.5 Zinc ﬁnger, NFX1-type containing 1 DNA exonuclease with putative function
during DNA repair
Perrino et al. (1994).
LGP2 2.18E−04 0.09 2.5 Laboratory of genetics and physiology 2 ISG. Inhibits IFN signaling by competing
with RIGI and MDA5
Yoneyama et al. (2005)
TREX1 1.62E−04 0.09 2.5 Three prime repair exonuclease 1 3′ 5′ DNA exonuclease activity. Contributes
to granzyme A induced cell death
Chowdhury et al. (2006).
SERTAD1 2.39E−04 0.10 2.5 SERTA domain containing 1 Acts at E2F responsive promoters stimulating
transcription factors and cyclin dependent kinase 4
Sugimoto et al. (1999).
TCF7L1 5.85E−04 0.13 2.5 Transcription factor 7-like 1 HMG box transcription factor involved
in induction of apoptosis
Franchini et al. (2006).
ATF3 1.37E−04 0.09 2.2 Cyclic AMP-dependent transcription
factor 3
Transcription factor member of CREB family.
Represses transcription. Induced by stress.
Promotes cell survival
Lu et al. (2007).
ISGF3G 3.54E−04 0.11 2.1 Interferon-stimulated transcription
factor 3, gamma (IRF9)
ISG. Transcription factor that mediates
IFN signaling inducing ISGs
Veals et al. (1992).
IER3 5.12E−04 0.12 2.1 Immediate early response 3 Prevents FAS or TNF induced apoptosis. Wu, (2003).
IRF8 1.26E−03 0.17 2.1 Interferon regulatory factor 8 ISG. Transcription factor that binds ISRE seq.
Required for expression of IFNs
Sharf et al. (1995)
DSCR1 9.39E−04 0.16 2.1 Down syndrome critical region gene 1 Transcription factor that inhibits
calcineurin-dependent signaling pathways.
Yamashita et al. (2000).
SLC25A28 4.95E−04 0.12 2.0 Solute carrier family 25,
member 28
Mithocondrial iron transporter that
mediates iron uptake
Li et al. (2001).
EIF4E 9.65E−04 0.16 2.0 Eukaryotic translation
initiation factor 4E
Protein that binds 5′mRNA cap, part of the
translation initiation complex that links
the RNA to the ribosomes.
Rychlik et al. (1987).
ZC3HAV1 7.77E−04 0.15 2.0 Zinc ﬁnger CCCH-type, antiviral 1 ISG. Inhibits retroviral gene expression
and induce an innate immunity response
Gao et al. (2002).
FAM46A 4.95E−04 0.12 2.0 Family with sequence similarity 46, member A Unknown function
MARCKSL1 1.32E−03 0.17 2.0 MARCKS-like 1 Might be involved in coupling protein kinase
C and calmodulin signal transduction pathways
Verghese et al. (1994).
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Table 2
Conﬁrmation of array results by real time RT-PCR. GAPDH was used as internal control
for data normalization.
Gene Fold induction: leaderless/WT
RT-PCR Array
CCL2 3.81±1.39 3.40
IFN-β 52.57±12.66 NIa
IL28B 15.51±7.80 3.80
ISG15 12.56±8.15 6.90
La35 0.98±0.07 1.00
Mx1 5.02±2.52 2.60
OAS1 4.87±2.32 3.80
PKR 2.26±0.70 1.80
GAPDH 1.00±0.00 1.00
FMDV 0.15±0.00 0.13
a NI: not included. This gene was not represented in the microarray.
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concluded that NF-κB binding sites are the most over-represented in
the DEGs, considering all known promoter recognition sequences. Six
out of the top eight most signiﬁcantly over-represented sequences are
NF-κB binding sites with P-values≤8.83E−21. The NF-kappaB (p50)
binding site from theM00051 sequencematrix was themost frequent
(P-value=3.46E−35). Although not in the top eight, the representa-
tion of the binding site for c-Rel, another member of the NF-κB family,
was also highly signiﬁcant (P-value=4.18E−11). Binding sites for
IRFs and for ISGF3G (listed in the table as ISRE) were also signiﬁcantly
over-represented using this analysis, with P-values of 4.34 E−05 and
6.01E−05 respectively. In addition, the NF-κB (p50) binding site
was over-represented in 22 out of 35 DEG regulatory sequences with
P-values between 9.1E−03 and 5.4E−15 (Supplementary Table 2).
Interestingly, binding sites for transcription factors ISGF3G and IRF8
were over-represented in 2 of the 22 genes containing NF-κB binding
sites, and moreover, the promoter sequence of IL28B that can lead to
activation of ISGF3G also contains over-represented NF-kappaB
binding sites. These results suggest that NF-κB dependent transcrip-
tion is primarily responsible for the differential gene expression
observed in leaderless vs WT FMDV infected cells.
Biological processes affected by differential expression
To identify the cellular processes that could be associated with the
differential gene expression, we used the GenMapp program. ThisTable 3
Signiﬁcantly over-represented transcription factor binding sites in DEGs. Promoter
sequences were analyzed using OTFBS software.
Bovine promoter sequences
Matrixa Transcription
factor binding site
Transcription
factor
Threshold Hits P-value
M00253 V$CAP_01 Cap signal for
transcription
initiation
0.98 74 2.04E−06
M00258 V$ISRE_01 ISGF3G 0.85 33 3.66E−18
M00062 V$IRF1_01 IRF-1 0.83 34 1.72E−09
M00063 V$IRF2_01 IRF-2 0.77 79 2.10E−09
M00194 V$NFKB_Q6 NF-kappaB 0.77 137 1.04E−08
M00054 V$NFKAPPAB_01 NF-kappaB 0.87 37 1.25E−06
M00053 V$CREL_01 c-Rel 0.82 124 5.92E−05
Human promoter sequences
Matrixa Transcription
factor binding site
Transcription
factor
Threshold Hits P-value
M00194 V$NFKB_Q6 NF-kappaB 0.77 110 3.74E−07
M00258 V$ISRE_01 ISGF3G 0.91 11 5.38E−09
a Matrix: different combinations of nucleotide sequences that can be recognized by
speciﬁc transcription factors.program tested if DEGs are signiﬁcantly over-represented within a list
of genes involved in a known particular biological process or pathway.
We observed that the detected DEGs were signiﬁcantly over-
represented in the gene list of apoptosis, protein ubiquitination and
response to “pest, pathogen, and parasite”, as deﬁned by the software,
with permutated P-values of 0.017, b0.001, and b0.001, respectively.
In the detailed analysis of response to pest, pathogen and parasite, the
response to virus, inﬂammatory response, and detection of pest,
pathogen and parasite, were signiﬁcant (P-valuesb0.001, 0.004, and
b0.001 respectively). These results suggested that the differential
gene expression between leaderless and WT FMDV infection reﬂects
mechanisms that are known to relate to evasion of the cellular innate
immune response to virus infection.
Differential gene expression in EBK cells infected with leaderless or SAP
mutant FMDV in relation to WT FMDV
We have previously shown that leaderless virus grows more
slowly than WT virus in secondary bovine cells (Chinsangaram et al.,
1999). Indeed, inclusion of FMDV probes in the microarray allowed us
to determine that by 4 hpi there was an average of 8 fold more viral
RNA in WT as compared to leaderless virus infected EBK cells.
Furthermore, relative quantitation of the viral RNA by qRT-PCR
yielded a 6.7 fold higher level for WT as compared to leaderless virus
infected cells conﬁrming themicroarray result (Table 2). To verify that
the differential gene expression betweenWT and leaderless virus was
not simply due to the signiﬁcant differences in the amount of viral
RNA present during the infection, we used a recently identiﬁed
mutant of FMDV, SAP, that has point mutations in the Lpro coding
region; the SAPmutant is defective in inducing NF-κB degradation but
not in cleaving eIF4G and can grow better than leaderless virus in cell
culture (de los Santos et al., 2009). The differential gene expression for
the SAP mutant with respect to WT virus was determined and a
control with leaderless vs WT was run at the same time (Table 6). The
relative average fold induction of the 39 DEGs for the SAPmutant with
respect to WT was 3.05 as compared to 2.56 for leaderless with
respect to WT. Statistical analysis showed high correlation between
the two data sets with a correlation coefﬁcient value of 0.92
(Pb0.0001) indicating that there were no signiﬁcant differences
between the samples (SAP vs WT compared to leaderless vs WT).
Comparison of the viral RNA levels in this microarray indicated that
there was only 1.56 fold more RNA in WT as compared to SAP mutant
virus infected cells, while there was 5.36 fold more RNA in WT as
compared to leaderless virus infected cells. Analysis of viral RNA by
qRT-PCR indicated relative values of 2.44 and 6.81 respectively. In
sum, cells infected with the SAP mutant had similar gene expression
proﬁles as cells infected with leaderless virus despite the presence of
about 3 times more FMDV RNA by 4 hpi.
Discussion
Previously, we have observed that the induction of transcription of
IFN-β and some ISGs was signiﬁcantly higher in porcine cells infected
with leaderless as compared to WT FMDV (de los Santos et al., 2006).
In this study, using microarray technology, we have analyzed 43,803
gene probes representing approximately 22,000 genes, to determine
the differences in host gene expression in bovine cells infected with
leaderless or WT FMDV.We took samples at 4 hpi because we wanted
to examine early responses that could provide information about
primary effects on host transcription. Within the limitations of our
system, e.g. 5% of the bovine genome was not covered by the
microarray and an arbitrary cut off set at 2 fold, we found that 39
genes were signiﬁcantly and differentially up-regulated in leaderless
as compared to WT FMDV infected cells and no signiﬁcant differential
gene down-regulation was observed. Conﬁrmation of some of these
results by qRT-PCR showed higher sensitivity, suggesting that more
Table 4
Number of transcription factor binding sites in the regulatory regions of DEGs, average microarray signal intensity and relative fold changes.
Genes ISREa,b IRF1a,c IRF2a,d c-Rela,e NFKAPPAB a,f NFKBa,g Intensity Fold change
IFIT2 4 4 6 5 2 3 334 11.5
RSAD2 2 2 3 1 0 2 404 8.1
PMAIP1 2 1 2 6 0 2 138 7.1
ISG15 6 6 4 4 1 1 2504 6.9
CXCL3 0 1 1 5 2 3 112 4.7
SAT1 0 0 1 2 1 5 153 4.5
IL28B 2 3 3 4 1 2 110 3.8
OAS1 2 3 4 4 1 1 1013 3.8
GTF2B 1 0 1 4 2 2 435 3.4
USP18 0 2 3 3 1 1 476 3.4
CCL2 0 0 4 1 0 3 1313 3.4
SOCS1 1 2 2 4 1 1 93 3.3
PARP14 0 0 0 2 1 3 188 3.1
C6orf150 0 1 3 2 0 1 79 3.0
NFKBIA 0 0 2 8 4 7 585 2.9
IFI6 4 3 6 3 2 2 78 2.9
DTX3L 2 2 2 4 1 5 710 2.7
FBXO33 0 0 2 3 0 2 377 2.6
MX1 2 1 2 3 2 5 465 2.6
GBP1 1 0 0 0 0 0 535 2.6
UBE1L 0 0 2 1 1 2 476 2.5
ZNFX1 1 1 3 6 3 6 304 2.5
LGP2 0 1 0 2 1 4 108 2.5
TREX1 0 0 0 2 2 2 94 2.5
SERTAD1 0 0 2 0 0 1 192 2.5
ATF3 0 0 0 2 0 5 845 2.2
ISGF3G 0 0 3 1 0 4 1030 2.1
IER3 0 0 0 2 1 3 195 2.1
IRF8 0 0 0 2 1 3 155 2.1
DSCR1 0 1 2 3 1 2 858 2.1
SLC25A28 1 1 1 0 0 0 95 2.0
EIF4E 1 1 1 0 0 0 189 2.0
ZC3HAV1 1 0 1 3 1 2 225 2.0
FAM46A 0 0 1 3 0 4 227 2.0
MARCKSL1 0 2 4 0 0 2 153 2.0
a Transcription binding sites are spelled as in the database according to the matrices numbers.
b M00258.
c M00062.
d M00063.
e M00053.
f M00054.
g M00194.
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considered that our sample was large enough for further analysis to
determine if a global control mechanism was involved. Most of theTable 5
Over-represented transcription factor binding sites in the promoter regions of DEGs calcula
Patterna P-value Name
M00051 3.46E−35 NF-kappaB (p50)
M00803 4.66E−29 E2F
M00054 1.53E−27 NF-kappaB
M00208 1.32E−23 NF-kappaB binding site
M00194 1.34E−23 NF-kappaB
M00052 2.67E−22 NF-kappaB (p65)
M00716 3.91E−21 ZF5
M00774 8.83E−21 NF-kappaB
M00189 1.15E−13 Activator protein 2
M00196 5.44E−13 Stimulating protein 1
M00469 7.55E−13 AP-2α
M00800 2.73E−12 AP-2
M00324 1.52E−11 Muscle initiator sequence-20
M00652 2.27E−11 Nrf-1
M00053 4.18E−11 c-Rel
M00256 6.58E−10 Neuron-restrictive silencer factor
M00470 8.27E−10 AP-2γ
M00321 2.17E−09 Muscle initiator
M00257 3.52E−07 Ras-responsive element binding protein 1
M00255 6.36E−07 GC box elements
M00323 8.87E−07 Muscle initiator sequences-19
M00721 1.01E−06 CACCC-binding factor
a Equivalent to matrix numbers: different combinations of nucleotide sequences that canup-regulated genes in leaderless virus infected cells are implicated in
the innate immune response to pathogen infection. More importantly,
the data suggests that the presence of Lpro correlates with a block inted with CARRIE.
Pattern P-value Name
M00514 2.14E−06 Activating transcription factor 4
M00695 2.94E−06 ETF
M00106 4.53E−06 Cut-like homeodomain protein
M00322 4.53E−06 c-Myc/Max binding sites
M00699 5.56E−06 ICSBP
M00114 1.04E−05 Tax/CREB complex
M00199 1.31E−05 AP-1 binding site
M00037 1.32E−05 NF-E2 p45
M00232 2.54E−05 Myogenic MADS factor MEF-2
M00720 2.90E−05 CAC-binding protein
M00684 3.06E−05 XPF-1
M00332 3.21E−05 Winged-helix factor nude
M00650 3.74E−05 MTF-1
M00480 4.32E−05 LUN-1
M00772 4.34E−05 IRF
M00619 5.31E−05 Alx-4
M00083 5.81E−05 MZF1
M00258 6.01E−05 ISRE
M00104 7.99E−05 Cut-like homeodomain protein
M00025 8.71E−05 Elk-1
M00797 8.71E−05 Hypoxia induced factor
be recognized by speciﬁc transcription factors.
Table 6
Gene expression proﬁles in EBK cells infected with SAP or leaderless relative to WT
FMDV.
Genea SAPb LLVc Gene SAP LLV Gene SAP LLV
IFIT2 9.8 8.9 NFKBIA 3.0 3.5 ZNFX1 2.0 1.5
RSAD2 8.9 5.8 ZC3HAV1 3.0 2.4 UBE1L 2.0 1.7
BATF2 5.4 4.1 OAS1 2.9 1.9 ZFP36 1.9 2.3
ISG15 5.0 4.3 DTX3L 2.7 1.8 PARP14 1.9 1.4
IL28B 4.8 7.3 CXCL3 2.5 2.3 MARCKSL1 1.9 1.7
SAT1 4.7 5.1 GBP1 2.4 1.6 ATF3 1.8 2.2
PMAIP1 4.3 4.2 MX1 2.3 1.8 FBXO33 1.8 1.4
FAM46A 4.1 2.9 IFI6 2.3 1.9 SERTAD1 1.7 1.7
CCL2 3.7 3.4 C6orf150 2.2 1.7 DSCR1 1.6 1.5
USP18 3.6 2.3 TREX1 2.2 1.8 IRF8 1.5 1.2
SOCS1 3.5 3.6 ISGF3G 2.2 1.9 IER3 1.4 1.4
TCF7L1 3.3 2.3 GTF2B 2.1 1.9 EIF4E 1.4 1.2
CX3CL1 3.2 1.8 LGP2 2.1 1.6 SLC25A28 1.4 1.2
a Gene name abbreviation.
b Relative gene expression in SAP vs WT FMDV (Cy3 labeled SAP vs Cy5 labeled WT).
c Relative gene expression in leaderless (LLV) vs WT FMDV (Cy3 labeled LLV vs Cy5
labeled WT).
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ubiquitous transcription factor NF-κB and possibly the IFN induced
transcription factor ISGF3G, also known as IRF9.
Among the DEGs in leaderless vs WT FMDV infection, the highest
difference, 11.5 fold, was observed for IFIT2 (ISG54). The product of
IFIT2 is a protein that binds eIF3 and blocks translation (Terenzi et al.,
2006). Interestingly, one of the best characterized functions of FMDV
Lpro is its ability to cleave the translation initiation factor eIF4G
resulting in the shut off of host cap-dependent translation without
affecting the viral IRES dependent translation (Devaney et al., 1988).
Since eIF3 is required for both, cellular and viral translation, it is
possible that WT FMDV may beneﬁt from decreasing the levels of
IFIT2 therefore reducing its inhibitory effect on eIF3. We also found
that eIF4E, a translation factor required for binding the 7 methyl-
guanosine cap of cellular RNAs (Rychlik et al., 1987), was expressed at
two-fold higher levels in leaderless infected cells as compared to WT
infected cells; likewise, a decreased amount of eIF4E may contribute
to the reduction of host cap-dependent translation observed during
FMDV infection.
Another group of genes up-regulated in leaderless vs WT virus
infected cells, included those involved in post-translational protein
modiﬁcation and among them, ISG15, an ubiquitin-like modiﬁer
whose expression rapidly increases after IFN treatment or viral
infection (Haas et al., 1987). Recent studies have shown that, in vivo,
ISG15 functions as a critical antiviral molecule against inﬂuenza,
herpes and Sindbis viruses (Lenschow et al., 2007) although the
mechanism of action still remains unclear. Moreover, ISG15 has been
reported as an important factor for dendritic cell (DC) maturation
(Padovan et al., 2002).
We also identiﬁed some cytokines/chemokines with higher levels
of expression in leaderless vsWT virus infected cells. Because the IFN-
β gene probe was not present in the microarray, we tested its
expression by qRT-PCR. Similar to our earlier studies, infection of
primary EBK cells showed that leaderless virus was a more potent
inducer of IFN-β transcription as compared toWT virus (de los Santos
et al., 2006, 2007) indicating that, Lpro blocks expression of IFN-β.
Interestingly, expression of a bovine gene homologous to a recently
discovered cytokine, IL28B (Kotenko et al., 2003; Sheppard et al.,
2003), reached higher levels upon infection with leaderless as
compared to WT virus. This cytokine has been classiﬁed as a new
member of the IFN gene family, type III IFN, and has antiviral activity
against a selected group of viruses (Ank et al., 2006). Higher levels of
mRNA for the chemokines CCL2, CXCL3 and CX3CL1 were also
detected in leaderless virus infected cells. Our group has observed thattreatment of swine with type I and type II IFNs induces expression of
CCL2, which may be involved in conferring cell-mediated protection
against FMDV (Diaz-San Segundo et al., 2010).
Lpro also inhibited the expression of other genes with known
antiviral properties including OAS1 and Mx1. Since selective up-
regulation of PKR was not detected by the microarray, we measured it
by qRT-PCR and observed a modest selective up-regulation in the
expression (2.3 fold). Both PKR and OAS/RNase L have been shown to
inhibit FMDV replication (Chinsangaram et al., 2001, de los Santos
et al., 2006).
Increased expression of a group of genes that are inducers of
apoptosis, PMAIP1, SAT1, NF-κB1A, UBE1L, PARP14, TCF7L1, IER3 and
IFI6, in leaderless infected cells suggests thatWT FMDVmight have an
anti-apoptotic effect. However, the role of apoptosis during FMDV
infection is controversial; although some investigators have found
that FMDV induces apoptosis (Jin et al., 2007; Peng et al., 2004), others
have shown no effect either in vitro or in infected animals (Díaz-San
Segundo et al., 2006; de los Santos et al., 2007).
Our analysis of the promoter regions in genes differentially
expressed between WT and leaderless FMDV infected cells shows a
signiﬁcant over-representation of binding sites for several transcrip-
tion factors including NF-κB, ISGF3G, IRF1 and IRF2 that are involved
in the innate immune response, suggesting that these transcription
factors are responsible for the differential expression. We have
previously demonstrated that NF-κB dependent gene induction is
lower inWT than in leaderless virus infected cells (de los Santos et al.,
2007, 2009). Our results on promoter sequence analysis show that the
binding motif sequences for NF-κB are the most over-represented in
the promoter sequence of the detected DEGs and the binding sites of
NF-κB were also found in the promoter sequences of ISGF3G and IRFs.
Moreover, relative quantitation of IFN-β by qRT-PCR whose tran-
scription depends on the transcription factors NF-κB, IRFs and AP1
(Thanos and Maniatis, 1995; Honda et al., 2006), detected 50 fold
more RNA in leaderless vs WT infected cells, consistent with our
previous observations. Based on these results we propose that NF-κB
is the primary effector of the differential gene expression observed by
infection with leaderless vs WT FMDV.
It is possible that this response is mainly triggered by higher
amounts of IFN protein in the culture media of leaderless as compared
to WT virus infected cells. However, we have been unable to detect
any difference in the amount of IFN protein in the supernatants of cells
infected with WT or leaderless virus by 4 hpi although differences are
detectable at later times, e.g. 16–24 hpi (Chinsangaram et al., 1999; de
los Santos et al., 2006, 2009). Type I and type III IFN proteins induce
transcription of ISGs through the binding of the STATs/ISGF3G protein
complexes to ISRE elements contained within regulatory elements of
promoter regions (Stark et al., 1998). In fact, we detected ISRE
elements over-represented in the promoter analyses but not at a
frequency as high as NF-κB sites (Table 4). Furthermore, up-regulation
of several genes which do not contain ISREs in their promoters or
whose transcription depends directly on viral infection, suggests that
this effect might be secondary to the effect of NF-κB or other IRFs (e.g.
IRF3) that do not require IFN protein for activation (Thanos and
Maniatis, 1995; Onoguchi et al., 2007; Osterlund et al., 2007).
It is important to consider the differences of growth kinetics of
leaderless virus as compared to WT virus at the time of sampling. The
array data for FMDV probes showed that by 4 hpi, there was
approximately an 8 fold higher level of viral RNA in WT as compared
to leaderless virus infected cells, evenwhen the samenumber of cells is
infected based on an infectious center assay (Chinsangaram et al.,
1999). To address this issuewe utilized a virus that containsmutations
in Lpro (SAP mutant virus). The SAP mutant does not induce
degradation of NF-κB and grows to higher titers than leaderless
virus, inducing transcription of IFN-β to similar or sometimes higher
levels than the leaderless virus (de los Santos et al., 2009). Microarray
analysis showed that infection with SAP mutant virus resulted in
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leaderless virus with respect toWT virus with a correlation coefﬁcient
of 0.92, even though the level of FMDV RNA in SAP virus infected cells
was about 3 fold higher than the level of RNA in leaderless virus
infected cells. These results suggest that the differential pattern of gene
expression in leaderless vs WT virus infected cells may reﬂect the
inability of leaderless virus to cause NF-κB degradation instead of the
reduced expression of other viral proteins. Moreover, the actual
difference in protein expression of DEGs is probably greater than gene
expression in leaderless as compared toWTvirus infection considering
the inhibition of cellular translation by Lpro.
In summary, our microarray data analysis suggests that the
majority of the genes differentially expressed in cells infected with
FMDV WT vs leaderless or SAP mutants, are involved in the innate
immune response. Above all, NF-κB is the primary factor responsible
for the differential transcription. These results support our earlier
experimental work which demonstrated that Lpro dependent degra-
dation of NF-κB contributes to FMDV evasion of the immune
response.
Materials and methods
Cells and viruses
Primary EBK cells were provided by the Animal, Plant, and Health
Inspection Service, National Veterinary Service Laboratory, Ames,
Iowa. These cells were maintained in minimal essential medium
(MEM, GIBCO BRL, Invitrogen, Carlsbad, CA) containing 10% fetal
bovine serum and supplemented with 1% antibiotics and non-
essential amino acids. BHK-21 cells (baby hamster kidney cells strain
21, clone 13, ATCC CL10), obtained from the American Type Culture
Collection (ATCC, Rockville, MD) were maintained in MEM containing
10% calf serum and 10% tryptose phosphate broth supplemented with
1% antibiotics and non-essential amino acids and used to propagate
virus stocks and measure virus titers. Cell cultures were incubated at
37 °C in 5% CO2. FMDV A12-WT virus was generated from the full-
length serotype A12 infectious clone, pRMC35 (Rieder et al., 1993),
FMDV A12-LLV2 (leaderless virus) was derived from the infectious
clone lacking the Lb coding region, pRM-LLV2 (Piccone et al., 1995)
and FMDV A12#49 (SAP mutant) was derived from the infectious
clone containing I55A and L58A mutations in the Lb coding region (de
los Santos et al., 2009).
FMDV infections
Primary EBK cell cultures were infected with FMDV at anMOI of 10
for 30 min at 4 °C followed by 30 min at 37 °C. After adsorption, cells
were rinsed twice and incubatedwithMEM at 37 °C for 2, 4 and 6 h. At
the end of the incubation period, cells were rinsed with PBS and lysed
in RLT buffer (Qiagen, Valencia, CA) for RNA extraction. Mock-infected
control cells were treated identically. Four independent experiments
using different lots of EBK cells were performed.
RNA isolation
Total RNA was isolated using an RNeasy isolation kit (Qiagen)
following the manufacturer's directions. RNA yield and quality was
determined in a NanoDrop 1000 spectrophotometer (Thermo Fisher,
Walthman, MA) and in a 2000 Bioanalyzer (Agilent Technologies,
Santa Clara, CA).
DNA microarray design
All bovine expressed sequence tags (ESTs) and RNA sequences
were downloaded from the National Center for Biotechnology
Information (NCBI) database and assembled into unique sequencesusing CAP3 software (Huang and Madan, 1999). The assembled
sequences were aligned with the bovine genome sequences and
displayed on the University of California Santa Clara (UCSC) genome
browser (Karolchik et al., 2003). Non-redundant bovine expressed
sequences including predicted gene sequences with homology to
genes of other species but without EST or RNA information were
selected for probe design. RepeatMasker software (http://www.
repeatmasker.org) was used to avoid repetitive DNA sequences in the
probe design. The probe sequences were designed with bias towards
the 3′-end of RNA sequences to increase signal intensity obtained
with labeling chemistry using poly-T priming. A custom bovine whole
genome expression microarray with 43,803 60-oligonucleotide sense
probes was designed with Array Designer 4.0 software (Applied
Biosystems, Foster City, CA). The annotation of the bovine microarray
was based on the results of BLAST (NCBI) against human reference
proteins/RNAs and non-reference RNAs and manual curation was
based on the probe sequence locations in the bovine genome
sequence and genetic information displayed on the UCSC genome
browser. The custom designed bovine microarrays were manufac-
tured by Agilent Technologies (Santa Clara, CA).
Microarray analysis
For themicroarray analysis of leaderless vsWT, total RNA prepared
from virus- or mock-infected samples was labeled using Agilent low-
input RNA labeling kit following the manufacturer's directions
(Agilent Technologies). RNA extracted from infected cells was labeled
with Cy5, and RNA extracted frommock-infected samples was labeled
with Cy3. Cy3-labeled RNA from mock-infected control was co-
hybridized with a Cy5-labeled RNA sample derived from WT or
leaderless virus infected samples per array. For the microarray
analysis of SAP vs WT, total RNA isolated from infected cells was
labeled with Cy3 for the SAP mutant (or leaderless virus run in a
parallel control experiment) and with Cy5 for the WT, as indicated
earlier. Cy3-labeled RNA from SAP (or leaderless) infected cells was
co-hybridized with Cy5-labeled RNA from WT infected cells. The
entire procedure of microarray analysis was conducted according to
protocols provided by Agilent Technologies. Array slides were
scanned using a GenePix 4000B scanner and GenePix Pro 6 program
(Molecular Devices Sunnyvale, CA) at 10 µm resolution with a spot
diameter of approximately 100 µm.
Data analysis
The expression data were extracted and ﬁltered based on feature
quality and signal intensity with criteria recommended in GenPix Pro
6.0 program (Molecular Devices). Data were imported into a SQL
database created with Microsoft SQL Server 2000 (Microsoft, Red-
mond, WA) and normalized with the LOWESS program implemented
in Acuity® 4.0 Enterprise Microarray Informatics software (Molecular
Devices). After normalization, only the features that passed quality
check in all four samples (WT, leaderless, SAP and mock-infected)
were included in the following analysis: Log ratios, Log2 (infected/
mock-infected), were calculated for t-test statistical analysis and P-
value correction for multiple statistical tests was conducted using
false discovery rate (Q-value) calculated with EDGE program (Leek
et al., 2006). Signiﬁcant differential gene expression between
leaderless and WT virus infected cultures was determined at the
false discovery rate of 0.20 with |Log ratio| equal to or greater than 1
(equivalent to a 2 fold difference).
The transcription regulatory sequences (600 base pairs upstream
of the promoters) of differentially expressed genes were extracted
from the bovine genome sequence based on both, NNPP software
(Reese, 2001) and the 5′-end of expressed sequences if available.
Over-represented cis-elements or transcription factor binding sites in
the regulatory sequences were identiﬁed and analyzed with the
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involved in the differential expression. This program compares
selected regulatory DNA sequences to default random sequences
based on statistical analysis for over-representation. For comparison,
human promoter sequences of genes with differential expression
were downloaded from PromoSer database (Halees et al., 2003) and
analyzed with the same software. For inferential statistics, correlation
between the number of transcription factor binding sites and signal
intensity, fold change, and impact factor (product of signal intensity
and fold change) were determined and analyzed with the SAS
program (SAS Institute Inc., Cary, NC). Signiﬁcant correlations were
declared for P-values≤0.05.
Analysis of transcription regulatory network involved in differen-
tial expression was performed with CARRIE software (Haverty et al.,
2004). Because a bovine promoter database is not available, the entire
set of human promoter sequences was downloaded from PromoSer
database and used for the analysis except that human promoter
sequences of the differentially expressed genes detected in this
experiment were substituted with corresponding bovine promoter
sequences identiﬁed as stated earlier. This program is a computational
method that analyzes microarray data including signal intensity, fold
changes, and promoter sequence data to infer a transcriptional
regulatory network from the response to a speciﬁc stimulus. The
promoter sequences of genes with least differences between the
treatments were selected by the program based on the microarray
data as the control sequences for the statistical analysis of over-
representation of transcription binding sites. P-values were adjusted
with the option provided in the program to account for multiple
statistical tests in one experimental project. To identify biological
processes affected by the differential expression, GenMAPP 2 software
(Salomonis et al., 2007) was applied for statistical analysis.
Analysis of mRNA by polymerase chain reaction (PCR)
A quantitative (real-time) reverse transcription PCR (qRT-PCR)
assay was used to conﬁrm results obtained with the microarray.
Standard procedures were followed (de los Santos et al., 2007). Eight
genes with different fold change were selected for the test, including
IFN-β which was not included in the microarray and PKR which was
only induced 1.8 fold, both previously reported to be affected by
FMDV infection (de los Santos et al., 2006). La35 with unchanged
expression in the microarray was included as a control. The sequences
of primers and probes are listed in Supplementary Table 4.
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